Back

prof. dr. P.O. (Els) Witteveen

prof. dr. P.O. (Els) Witteveen

Full Professor
prof. dr. P.O. (Els) Witteveen
  • Dept of Medical Oncology

Research Programs

Cancer

Side Activities

2021 Editorial Board Member European Journal of Gynaecological Oncology

2018 Chair Central Incident Committee (MIP commissie)

2018 Dutch working group on Evidence Based Guidelines in Ovarian Cancer

2018 Dutch working group on Evidence Based Guidelines in Endometrial Cancer

2018 Dutch working group on Evidence Based Guidelines in Cervical Cancer

2015 Advisory board Priority Program Cancer, University Medical Center Utrecht, Cancer Center

2015 Steering Committee Expensive Medicines, University Medical Center Utrecht, Cancer Center

2014 Member Dutch Advisory group Cancer in pregnancy (AKZ)

2013 Dutch working Group on Evidence Based guidelines on fertility preservation in Cancer Treatment

2013 Member of working group NFU oncology on behalf of University Medical Center Utrecht, Cancer Center

2005 Working group on gynaecological cancers of the comprehensive cancer center Utrecht (TWGO)

Research Output (141)

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer:A biomarker-enriched phase II study

Embaby Alaa, Kutzera Joachim, Geenen Jill J, Pluim Dick, Hofland Ingrid, Sanders Joyce, Lopez-Yurda Marta, Beijnen Jos H, Huitema Alwin D R, Witteveen Petronella O, Steeghs Neeltje, van Haaften Gijs, van Vugt Marcel A T M, de Ridder Jeroen, Opdam Frans L 24 May 2023, In: Gynecologic Oncology. 174 , p. 239-246 8 p.

Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands

Heimovaara Joosje H., Boere I. A., de Haan Jorine, van Calsteren Kristel, Amant F., van Zuylen Lia, Lok Christine A.R., Lok C. A.R., van Zuylen L., Boere I. A., Amant F., Beerendonk C. C.M., Bellido-Casado M., Beltman J. J., Bos M. E.M.M., Duvekot J. J., Gerestein C. G., Gordijn S., de Groot C. J.M., van Grotel M., Han S. N., Heeres B. C., van den Heuvel-Eibrink M. M., Houwink A., Huitema D. R., Koken Ph W., Koppert L. B., Lugtenburg P. J., Ottevanger P. B., Painter R. C., Poortmans P. M.P., Roes E. M., van der Scheer L., Schröder C. P., Suelmann B. B.M., Suijkerbuijk K. P.M., van Tienhoven G., van Trommel N. E., Trum J. W., van der Velden J., Vriens I. J.H., Witteveen P. O., Aug 2022, In: European Journal of Cancer. 171 , p. 13-21 9 p.

Response to Systemic Therapies in Ovarian Adult Granulosa Cell Tumors:A Literature Review

Brink Geertruid J, Groeneweg Jolijn W, Hooft Lotty, Zweemer Ronald P, Witteveen Petronella O 17 Jun 2022, In: Cancers. 14 , p. 1-15

Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer

de Witte Chris J, Kutzera Joachim, van Hoeck Arne, Nguyen Luan, Boere Ingrid A, Jalving Mathilde, Ottevanger Petronella B, van Schaik-van de Mheen Christa, Stevense Marion, Kloosterman Wigard P, Zweemer Ronald P, Cuppen Edwin, Witteveen Petronella O 2 Mar 2022, In: Cancers. 14 , p. 1-18

The association between patient satisfaction with information and adherence to oral anticancer agents

Melis Eward J, Zwart-van Rijkom Jeannette Ef, Egberts Toine Cg, van den Bemt Bart Jf, Witteveen Petronella O, Gardarsdottir Helga 7 Feb 2022, In: Journal of Oncology Pharmacy Practice. 29 , p. 637-645 9 p.

Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)

Post C C B, Westermann A M, Boere I A, Witteveen P O, Ottevanger P B, Sonke G S, Lalisang R I, Putter H, Meershoek-Klein Kranenbarg E, Braak J P B M, Creutzberg C L, Bosse T, Kroep J R 2022, In: Gynecologic Oncology. 165 , p. 223-229 7 p.

Frailty and checkpoint inhibitor toxicity in older patients with melanoma

Bruijnen Cheryl P., Koldenhof José J., Verheijden Rik J., van den Bos Frederiek, Emmelot-Vonk Mariëlle H., Witteveen Petronella O., Suijkerbuijk Karijn P.M. 2022, In: Cancer. 128 , p. 2746-2752 7 p.

Patient-reported outcomes during checkpoint inhibition:insight into symptom burden in daily clinical practice

Koldenhof J J, van der Baan F H, Verberne E G, Kamphuis A M, Verheijden R J, Tonk E H, van Lindert A S, van der Stap J, Teunissen S C, Witteveen P O, Suijkerbuijk K P 2022, In: Journal of Pain and Symptom Management. 63 , p. 997-1005 9 p.

Functional decline after surgery in older patients with head and neck cancer

Bruijnen Cheryl P., de Groot Lotte G.R., Vondeling Ariel M., de Bree Remco, van den Bos Frederiek, Witteveen Petronella O., Emmelot- Vonk Mariëlle H. 30 Oct 2021, In: Oral Oncology. 123

IMPACT OF HORMONAL BIOMARKERS ON RESPONSE TO HORMONAL THERAPY IN ADVANCED AND RECURRENT ENDOMETRIAL CANCER

VAN Weelden Willem Jan, Lalisang Roy I, Bulten Johan, Lindemann Kristina, VAN Beekhuizen Heleen J, Trum Hans, Boll Dorry, Werner Henrica M J, VAN Lonkhuijzen Luc R C W, Yigit Refika, Forsse David, Witteveen Petronella O, Galaal Khadra, VAN Ginkel Alexandra, Bignotti Eliana, Weinberger Vit, Sweegers Sanne, Kroep Judith R, Cabrera Silvia, Snijders Marc P L M, Inda Márcia A, Eriksson Ane Gerda Z, Krakstad Camilla, Romano Andrea, VAN DE Stolpe Anja, Pijnenborg Johanna M A 18 May 2021, In: American Journal of Obstetrics and Gynecology. 225 , p. 407.e1-407.e16

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Contact

Afspraken

Praktisch

hetwkz.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not